An LXR agonist promotes GBM cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway

Glioblastoma (GBM) is the most common malignant primary brain tumor of adults and one of the most lethal of all cancers. EGFR mutations (EGFRvIII) and PI3K hyperactivation are common in GBM, promoting tumor growth and survival, including through SREBP-1-dependent-lipogenesis. The role of cholesterol...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Guo, Deliang, Reinitz, Felicia, Youssef, Mary, Hong, Cynthia, Nathanson, David, Akhavan, David, Kuga, Daisuke, Amzajerdi, Ali Nael, Soto, Horacio, Zhu, Shaojun, Babic, Ivan, Tanaka, Kazuhiro, Dang, Julie, Iwanami, Akio, Gini, Beatrice, DeJesus, Jason, Lisiero, Dominique D., Huang, Tiffany T., Prins, Robert M., Wen, Patrick Y., Robins, H. Ian, Prados, Michael D., DeAngelis, Lisa M., Mellinghoff, Ingo K., Mehta, Minesh P., James, C. David, Chakravarti, Arnab, Cloughesy, Timothy F., Tontonoz, Peter, Mischel, Paul S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3207317/
https://ncbi.nlm.nih.gov/pubmed/22059152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-11-0102
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky